Please sign in to follow a disease.
Disease characteristic
MONDO:0021125An attribute of a disease.
Also known as: disease qualifier, modifier, qualifier
18 clinical trials for this condition and its sub-types, 2 tagged with Disease characteristic itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease characteristic
-
Infectious disease characteristic 0 trials · 8 incl. sub-types
2 sub-types
- Opportunistic infectious 8 trials
- Primary infectious 0 trials
-
Hereditary vs non-hereditary etiology 0 trials · 4 incl. sub-types
2 sub-types
- Inherited 4 trials
- Non-genetic 0 trials
-
Tumor grading characteristic 0 trials · 3 incl. sub-types
1 sub-type
- General tumor grading characteristic 0 trials · 3 incl. sub-types Sub-types →
-
Congenital or acquired 1 trial · 2 incl. sub-types
2 sub-types
- Congenital 1 trial
- Acquired 0 trials
-
2 sub-types
- Classic presentation 0 trials
- Non-classic presentation 0 trials
-
Iatrogenic or non-iatrogenic 0 trials
2 sub-types
- Iatrogenic 0 trials
- Non-iatrogenic 0 trials
-
Idiopathic vs non-idiopathic 0 trials
2 sub-types
- Idiopathic 0 trials
- Non-idiopathic 0 trials
-
Locational disease characteristic 0 trials
2 sub-types
- Disseminated 0 trials
- Restricted to specific location 0 trials
-
Mosaic vs complete 0 trials
-
Rare or common 0 trials
-
Syndromic or isolated 0 trials
2 sub-types
- Has a syndromic presentation 0 trials
- Has an isolated presentation 0 trials
Most studied deeper sub-types
-
Lab-Grown tumor organoids could pick the right bladder chemo
Disease control Not yet recruitingResearchers are testing whether drug testing in patient-derived organoids can guide chemotherapy for low-grade non-muscle invasive bladder cancer. Adults with primary or recurrent low-grade bladder cancer receive one of four chemo drugs, epirubicin, mitomycin C, gemcitabine, or d…
Phase 2 • Sponsor: Hospital Centre Biel/Bienne • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Zapping kidney nerves: a Needle-Free hope for high blood pressure?
Disease control Not yet recruitingThis pilot study tests a new device that uses radiofrequency energy to calm overactive kidney nerves, which can drive high blood pressure. Twenty adults with untreated mild hypertension will either get the real procedure or a sham (fake) one. The main goal is to see if the real t…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Phase 1/2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
DNA test for infections: can it guide antibiotic decisions?
Diagnosis Not yet recruitingResearchers are running a large observational registry to see how a blood test called metagenomic sequencing is used in routine care for people with or at risk of serious infections, including those with weakened immune systems. The study enrolls participants at multiple hospital…
Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Gene hunt: could sequencing families unlock the roots of mysterious mental illness?
Knowledge-focused Not yet recruitingThis study investigates whether sequencing the genomes of patients with early-onset or unusual psychiatric disorders—along with their biological parents—can uncover hidden genetic causes. Researchers aim to find disease-related gene variants in at least 12% of participants aged 3…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New study to test antifungal drug safety in organ transplant patients
Knowledge-focused Not yet recruitingThis study will observe 120 solid organ transplant recipients who have invasive fungal infections. Researchers will track how well the drug liposomal amphotericin B works and its side effects, compared to historical patients who received other antifungal treatments. The goal is t…
Sponsor: Sichuan Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC